BASF and private equity firm Lone Star are in exclusive negotiations for the sale of BASF’s construction chemicals business, according to news agency Bloomberg.
The innovative medicine-enabling nanotechnology company, Nanoform, discusses the construction of its first GMP manufacturing facility for the manufacture of nanonised drug particles.
Swedish-based Recipharm has reached an agreement to acquire global drug delivery and device company Consort Medical of the UK, owner of Aesica Pharmaceuticals.